Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 833 citations

Drug Safety, Compromise Treatment, Pulmonary Tuberculosis +15

IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?

Raoul Poupon, RenéeE. Poupon, Yvon Calmus et al. · The Lancet · 1987 · 538 citations

Hepatology, Biliary Tract, Liver Physiology +9

Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

Yi‐Shin Huang, Herng‐Der Chern, Wei‐Juin Su et al. · Hepatology · 2002 · 430 citations

Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial

U. Leuschner, H Fischer, W Kurtz et al. · Gastroenterology · 1989 · 359 citations · Full text

Urology, Hepatology, Biliary Tract +11

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 333 citations

Immunology, Genetic Epidemiology, Pathology +22